Medcura raises $7.4 Million to Expand FDA-Approved Line of Hemostatic and Wound Treatment Products
RIVERDALE, Md., Aug. 12, 2021 /PRNewswire/ — Medcura, Inc., a commercial-stage medical device company, today announced it has raised $7.4 million in private equity to support its growing product line and development of its lead surgical candidate for clinical…
